163061-19-6

Basic information

• Product Name: N-BOC-L-PHENYLGLYCINAL
• Synonyms: N-BOC-L-PHENYLGLYCINAL;N-t-BOC-L-Phenylglycinal;Boc-L-phenylglycinal;(S)-tert-butyl 2-oxo-1-phenylethylcarbamate
• CAS NO: 163061-19-6
• Molecular Formula: C₁₃H₁₇NO₃
• Molecular Weight: 235.27898
• Mol File: 163061-19-6.mol
• Article Data: 24

Chemical Properties

• Boiling Point: 356.67 °C at 760 mmHg
• Flash Point: 169.508 °C
• Appearance: /
• Density: 1.093 g/cm³
• CAS DataBase Reference: N-BOC-L-PHENYLGLYCINAL(CAS DataBase Reference)
• NIST Chemistry Reference: N-BOC-L-PHENYLGLYCINAL(163061-19-6)
• EPA Substance Registry System: N-BOC-L-PHENYLGLYCINAL(163061-19-6)

Safety Data

• Hazard Codes: Xn
• Statements: 20/21/22-36/37/38-43
• Safety Statements: 26
• Hazardous Substances Data: 163061-19-6(Hazardous Substances Data)

Usage

General Description

N-BOC-L-PHENYLGLYCINAL, also known as N-t-BOC-L-phenylglycinal, is a chemical compound commonly used as an intermediate in the production of pharmaceuticals. It belongs to the class of amino acids and derivatives, specifically phenylglycine derivatives. The compound has a Boc-protected amine group, which makes it useful in peptide synthesis. N-BOC-L-PHENYLGLYCINAL is often employed as a starting material for the synthesis of various drugs and pharmaceutical compounds due to its reactivity and versatility in organic synthesis. It is also used as a research chemical in laboratories and has potential applications in medicinal chemistry and drug development.

Upstream product

• 6591-61-3 (S)-Phenylglycine methyl ester 
• 24424-99-5 di-tert-butyl dicarbonate 
• 502157-97-3 (2S)-2-phenyl-2-({[(1R)-1-phenyl-2-propenyl]amino}oxy)ethanol 
• 158851-29-7 (+)-tert-butyl [(1R)-1-phenylprop-2-en-1-yl]imidocarbonate 
• 368447-65-8 benzaldehyde (E)-O-[(1S)-2-hydroxy-1-phenylethyl]oxime 
• 325490-29-7 (1R)-1-phenylprop-2-en-1-amine 
• 15028-39-4 L-2-phenylglycine methyl ester hydrochloride 
• 2935-35-5 (S)-2-phenylglycine 
• 2900-27-8 (2S)-2-[(tert-butoxycarbonyl)amino]-2-phenylethanoic acid 
• 757195-52-1 tert-butyl (1S)-2,3-dihydroxy-1-phenylpropylcarbamate 
• 335628-13-2 (4S,5R)-5-benzyloxy-3-tert-butoxycarbonyl-4-phenyl-2-oxazolidinone 
• 216769-51-6 tert-butyl (S)-{2-[methoxy(methyl)amino]-2-oxo-1-phenylethyl}carbamate 
• 143978-88-5 N-tert-butoxycarbonyl-L-phenylglycine methyl ester 
• 117049-14-6 tert-butyl N-[(1S)-2-hydroxy-1-phenylethyl]carbamate 

Downstream Products

• 216769-56-1 (2E,4R)-4-(t-butoxycarbonylamino)-4-phenylbutenbutenoic acid methyl ester 
• 104700-39-2 (E)-ethyl 4-(tert-butoxycarbonylamino)-4-phenylbut-2-enoate 
• 54600-84-9 diethyl 2,2'-[(3,6-diphenylpyrazine)-2,5-diyl]diacetate 
• 136693-03-3 (+)-1,1-dimethylethyl (N-((1S,2S)-2-hydroxy-1-phenyl-3-butenyl)amino)methanoate 
• 136693-05-5 1,1-dimethylethyl (N-((1S,2S)-2-(1-ethoxyethoxy)-1-phenyl-3-butenyl)amino)methanoate 
• 160237-88-7 (4S,5S)-3-(tert-butoxycarbonyl)-2,2-dimethyl-4-phenyl-5-(2'-propenyl)-1,3-oxazolidine 
• 208935-40-4 (4S-trans)-4,5-dihydro-2,4-diphenyloxazoline-5-acetic Acid 

Relevant articles and documents

ERK INHIBITORS

The present invention provides a compound of Formula (I) or the pharmaceutically acceptable salts, esters, and prodrugs thereof, which are ERK2 inhibitors. The invention also provides a method of inhibiting ERK2 in a patient in need of such treatment comprising administering to said patient an effective amount of at least one compound of Formula (I). The invention also provides a method for treating cancer in a patient in need of such treatment, said method comprising administering to said patient an effective amount of at least one compound of Formula (I).

Synthesis of tetrasubstituted symmetrical pyrazines from β-keto γ-amino esters: A mild strategy for self-dimerization of peptides

A facile synthesis of highly symmetrical tetrasubstituted pyrazines through simple aerial oxidation of β-keto γ-amino esters is reported. The scope of the reaction was examined by use of various amino acid side-chain functional groups andpeptides. The mil

Hypervalent iodine/TEMPO-mediated oxidation in flow systems: A fast and efficient protocol for alcohol oxidation

Hypervalent iodine(III)/TEMPO-mediated oxidation of various aliphatic, aromatic and allylic alcohols to their corresponding carbonyl compounds was successfully achieved by using microreactor technology. This method can be used as an alternative for the oxidation of various alcohols achieving excellent yields and selectivities in significantly shortened reaction times.